🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ativsoftware.com/appinfo.php?pa… #ASH18 Amazing visualization of cells occupying hematopoietic niche!

#ASH2018 IACA dinner on ASH sidelines. Enjoying Dr. Uday Popat’s singing 🎤 Rakesh Goyal Graft versus Host

#TCTM19 Baricitinib-induces blockade of IFNGR and IL-6R, prevents and treats GVHD and has GVL effects in murine model. @BldCancerDoc Duy Khang Đỗ CIBMTR @NMDP @dharmabmt Satya Prakash Yadav

#tctm19 @ASBMT is now ASTCT 🎉🎈👏👏👏

So proud of @BldCancerDoc, a close friend and a born leader, for being elected as the President of ASBMT, now christened ASTCT (American Society of Transplantation and Cell Therapy)

Its official! Welcome Dr. Navneet Majhail - the incoming president of the ASTCT ⁦@ASBMT⁩ ⁦CIBMTR⁩ ⁦@BldCancerDoc⁩ ⁦Satya Prakash Yadav⁩

Shout out to the one-and-only, the always amazing, the brilliant and dynamic: @BldCancerDoc 👉👉👉Officially now Beginning his administration as the President of the now: American Society for Transplantation and Cellular Therapy, ASTCT {formerly Duy Khang Đỗ} #TCTM19 #bmtsm #ImmunoOnc

Hear from our new President on why we're changing our name and what's to come! Full video can be accessed on our Facebook page: bit.ly/2E4kf9Z

Fantastic news at #TCTM19 - Congratulations @BldCancerDoc! 💚💙

#TCTM19 a case of MDS not related to vector but use of alkylating agent

At ASBMT reception. #tctm19 Salahuddin Siddiqui

How to improve the diversity of your microbiome? 1, 2 & 3: Avoid unnecessary antibiotics. Probiotics are killed by stomach acid, and no one adheres to any diet.

I am humbled and honored to be selected for the #ASPHO Young Investigator Award. Look forward to presenting our research on the genetics of fetal hemoglobin regulation at American Society of Pediatric Hematology/Oncology annual meeting St. Jude Research St. Jude aspho.org/career-develop…

So proud to be part of the 2nd iNDUS meeting, #INDUSBMT19!

bit.ly/310cHje FDA approves ruxolitinib for steroid-refractory acute GVHD in adult and pediatric patients 12 years and older. The recommended starting dose of ruxolitinib for GVHD is 5 mg given orally twice daily bit.ly/2MklWY4 Graft versus Host GvHD Hub @BldCancerDoc

Our community has lost another pioneer and lifelong contributor to BMT. ASTCT sends its deepest condolences to the family, friends, colleagues & countless others impacted by Dr. Miller. Colleague McGlave says, "He was always excellent in a low-key way.” ow.ly/H48x50vt9ZJ

Targeting the Microbiome to Treat Malnutrition. An important study conducted in Bangladesh. Microbiome-friendly formulation of chickpea, soy, peanut, and banana. bit.ly/2M8wqZ2 Full text Science corrected proof bit.ly/2JZYKKf Miguel Regueiro michael morowitz Rakesh Goyal

ASH 2019: BCMA CAR-T, Immunotherapy and Developing a Myeloma Cure | Dr. ... youtu.be/Sx8VW1kDqIU via YouTube #ASH19 #mmsm sganguly

Outstanding job, Dr. Ganguly and colleagues.